Therapeutic considerations for postprandial dyslipidaemia
- 作者John R. Burnett; Gerald F. Watts
- 卷第3卷
- 期第3期
- 印刷ISSN1462-8902
- 电子ISSN1463-1326
- 文件大小206.95KB
- 发表时间2001
- DOI10.1046/j.1463-1326.2001.00155.x
- 页码143-156
Effect of fluvastatin on plasma fibrinogen levelsE. Liberopoulos; V. Tsimihodimos; E. Bairaktari; Ch. Tzallas; E. Rizos; A. Katsaraki; G. Miltiadous; M. Elisaf · 1999
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicV. Tsimihodimos; H. Milionis; E. Bairaktari; C. Tzallas; G. Miltiadous; A. Katsaraki; E. Liberopoulos; M. Elisaf · 1999
Comparison of the efficacy of atorvastatin and micronised fenofibrate in the treatment of mixed hyperlipidemiaG. Miltiadous; E. Bairaktari; C. Tzallas; V. Tsimihodimos; E. Liberopoulos; H. Milionis; E. Rizos; M. Elisaf · 1999
Effect of micronised fenofibrate and losartan combination on uric acid metabolism in hypertensive dyslipidemic patients with hyperuricemiaM. Elisaf; V. Tsimihodimos; E. Bairaktari; A. Katsaraki; Ch. Tzallas; G. Miltiadous; E. Liberopoulos; H. Milionis; A. Achimastos; K.C. Siamopoulos · 1999
Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjectsLiberopoulos, E. N.; Miltiadous, G. A.; Cariolou, M.; Kalaitzidis, R.; Siamopoulos, K. C.; Elisaf, M. S. · Nephrology Dialysis Transplantation · 2004
The Effect of Apolipoprotein E Polymorphism on the Response to Lipid-Lowering Treatment With Atorvastatin or FenofibrateChristidis, D. S.; Liberopoulos, E. N.; Kakafika, A. I.; Miltiadous, G. A.; Cariolou, M.; Ganotakis, E. S.; Mikhailidis, D. P.; Elisaf, M. S. · Journal of Cardiovascular Pharmacology and Therapeutics · 2006